Active

Viatris GX

Switched

BE0885805780

Rechtspersoon Private limited company 1 establishment

Terhulpsesteenweg 6A, 1560 Hoeilaart Groothandel in farmaceutische en medische artikelen

Active for

19 year, 8 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 0

Profit

Growing

€ 407,069

▲ 3% vs 2024

Debts

Low

€ 3.2 million

▼ 16% vs 2024

Viatris GX from Hoeilaart, company number BE0885805780, closed financial year 2025 with a result of € 407,069 after tax. For that financial year Viatris GX recorded a gross margin of € 0 and equity of € 27.9 million. Compared with financial year 2024, the result moved from € 395,432 to € 407,069. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What happened at Viatris GX?

What happened at Viatris GX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 407,069 (▲ 3% vs 2024). Source: NBB ↗
  • Arun NARAYAN became a director. NBB
  • Tomasz BUCZEK became a director. NBB
  • New establishment in Hoeilaart. KBO
  • Start of the company according to the CBE. KBO

In short

From € 172,077 profit in 2022 to € 407,069 profit in 2025.

Paid € 112,372 in corporate taxes since 2022.

Best year ever: 2023, with € 571,874 profit.

Pays suppliers within 49 days on average.

A new publication or filing at Viatris GX? We notify you, reason included.

Follow Viatris GX

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Mylan Luxembourg 6 S.à r.l. 100%
Viatris GX
DOCPHARMA 100%

Behind Viatris GX are Arun NARAYAN and Tomasz BUCZEK. The shares are held by Mylan Luxembourg 6 S.à r.l. (100%). It owns 100% of DOCPHARMA itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Arun NARAYAN

Director

Also active at: Viatris Healthcare, AKTUAPHARMA, DOCPHARMA +1 more

since 2025

Tomasz BUCZEK

Director

Also active at: Viatris Healthcare, Viatris

since 2025

Shareholders

Mylan Luxembourg 6 S.à r.l.

100%

Participations

Establishments

Establishment units

Physical locations of this company

Registered office

Terhulpsesteenweg 6A

1560 Hoeilaart

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

Details

Company number
0885.805.780
VAT number
BE 0885.805.780
Registered office
Terhulpsesteenweg 6A, 1560 Hoeilaart
Names & denominations
Viatris GX
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
20 December 2006
Peppol
Active · Active since 20 Nov 2020
Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

Frequently asked questions

What is the enterprise number of Viatris GX?
The enterprise number of Viatris GX is BE0885805780.
What is the address of Viatris GX?
The registered office of Viatris GX is located at Terhulpsesteenweg 6A, 1560 Hoeilaart.
When was Viatris GX founded?
Viatris GX was founded on 20 December 2006.
What is the main activity of Viatris GX?
The main activity of Viatris GX is "Groothandel in farmaceutische en medische artikelen" (NACE code 46460).
Does Viatris GX have a website?
No website is currently known for Viatris GX.
How much profit did Viatris GX make in 2025?
Viatris GX posted a profit after taxes of € 407,069 in financial year 2025.
Where can I find the annual accounts of Viatris GX?
Viatris GX files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Viatris GX?
According to the 2025 annual accounts, the directors of Viatris GX are: Arun NARAYAN, Tomasz BUCZEK.
Who owns Viatris GX?
Behind Viatris GX are Arun NARAYAN and Tomasz BUCZEK. The shares are held by Mylan Luxembourg 6 S.à r.l. (100%). It owns 100% of DOCPHARMA itself.
Who are the shareholders of Viatris GX?
According to the 2025 annual accounts, the shareholders of Viatris GX are: Mylan Luxembourg 6 S.à r.l. (100%).